US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi Genomics & Precision Medicine ETF

36.29

-0.3516-0.96%

Post-market: 36.290.00000.00%16:43 EDT

Volume:2K

Turnover:87.20K

Market Cap:2.72M

PE:- -

High:36.97

Open:36.97

Low:36.22

Close:36.64

52wk High:36.97

52wk Low:23.88

Shares:75.00K

Float Shares:75.00K

Volume Ratio:11.03

T/O Rate:3.18%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Steris PLC Stock Underperforms Tuesday When Compared to Competitors

Guardant Health Could Benefit From AstraZeneca Trial Failure, UBS Says

MT Newswires Live

Illumina Inc Stock (ILMN) Moved Up by 7.40% on Sep 15: Drivers Behind the Movement

ASX biotech expands diagnostics portfolio after FDA approval

Morning Star AU

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-09-15

Thermo Fisher Exec Says Academic and Government Research Market Should Return to Growth in 2027 - Morgan Stanley Conference

THOMSON REUTERS

Thermo Fisher Exec Says Orders are Outpacing Revenue, Boding Well for Future Growth- Morgan Stanley Conference

THOMSON REUTERS

Mayo Clinic and Thermo Fisher Scientific Launch Precure, Llc to Identify Signs of Disease Before Symptoms Appear

THOMSON REUTERS

Vertex Pharmaceuticals partners with Lindsey Vonn for JOURNAVX awareness

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC), Natera (NTRA) and Vertex Pharmaceuticals (VRTX)

Barclays downgrades Scholar Rock on valuation after FDA approval

Guardant Health CIO Kumud Kalia Disposes of 4,000 Common Shares Worth $632,193.20

Niki BioSolutions Highlights Strategic Synergies in Alzheimer’s Diagnostics

Guardant Health, - Evicore by Evernorth to Cover Shield Blood Test for Crc Screening Effective Jan 1, 2027

THOMSON REUTERS

Biofrontera announces FDA approval of Ameluz supplemental new drug application

Scholar Rock Wins FDA Approval for SMA Therapy

Scholar Rock price target raised to $84 from $76 at BMO Capital

Cellectis pivots to in vivo gene editing and exits key CAR-T programs

Cellectis Announces Strategic Transformation To In Vivo Gene Editing Company

Vertex Minerals Revises Timeline for Proposed Securities Issue

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/GNMX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"GNMX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","market":"US","secType":"STK","nameCN":"Corgi Genomics & Precision Medicine ETF","latestPrice":36.29,"timestamp":1789761600000,"preClose":36.6416,"halted":0,"volume":2383,"hourTrading":{"tag":"盘后","latestPrice":36.29,"preClose":36.29,"latestTime":"16:43 EDT","volume":37,"amount":1339.94,"timestamp":1789764180523,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.009595650844941206,"floatShares":75000,"shares":75000,"eps":0,"marketStatus":"Market Closed","change":-0.3516,"latestTime":"09-18 16:00:00 EDT","open":36.97,"high":36.97,"low":36.22,"amount":87203,"amplitude":0.020469,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1302235200000,"exchange":"CBOE","adjPreClose":36.6416,"nav":36.62,"aum":2746500,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":36.86,"preClose":36.6416,"latestTime":"09:29 EDT","volume":351,"amount":12937.86,"timestamp":1789738199999,"change":0.2184,"changeRate":0.00596,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":36.29,"preClose":36.29,"latestTime":"16:43 EDT","volume":37,"amount":1339.94,"timestamp":1789764180523,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":11.032410471965873,"impliedVol":0.0285,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","floatShares":75000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":11.032410471965873,"shares":75000,"dividePrice":0,"high":36.97,"amplitude":0.020469,"preClose":36.6416,"low":36.22,"week52Low":23.88,"pbRate":"--","week52High":36.97,"institutionHeld":0,"latestPrice":36.29,"eps":0,"divideRate":0,"volume":2383,"delay":0,"ttmEps":0,"open":36.97,"prevYearClose":25.56,"prevWeekClose":34.1467,"prevMonthClose":35.0802,"prevQuarterClose":31.0879,"fiveDayClose":34.1467,"twentyDayClose":35.1286,"sixtyDayClose":29.1881},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNMX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNMX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNMX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNMX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667432622","title":"Steris PLC Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667432622","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667432622?lang=en_us&edition=fundamental","pubTime":"2026-09-16 05:06","pubTimestamp":1789506360,"startTime":"0","endTime":"0","summary":"DJ Steris PLC Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Steris PLC  shed 1.58% to $210.28 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.45% to 7,585.73 and Dow Jones Industrial Average  falling 0.63% to 52,093.11.Steris PLC closed 21.96% short of its 52-week high of $269.44, which the company achieved on January 16th.The stock underperformed when compared to some of its competitors Tuesday, as Thermo Fisher Scientific Inc.  rose 4.61% to $641.39, Danaher Corp.  rose 3.01% to $209.36, and Becton Dickinson & Co.  rose 1.65% to $185.92.Trading volume  eclipsed its 50-day average volume of 684,040.Data source: Dow Jones Market Data, FactSet. Data compiled September 15, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289961442.SGD","TMO","FMED","LU1670627923.USD","LU0072461881.USD","LU1150488135.SGD","LU0175139822.USD","LU0689472784.USD","LU0882574055.USD","LU1366333091.USD","LU0511384066.AUD","LU1892829315.USD","LU1150488218.USD","LU2125910336.SGD","LU2298321311.HKD","DHR","LU0068578508.USD","LU1153585028.USD","BK4121","LU1291159041.SGD","IE00B19Z8W00.USD","HRTS","BDX","SG9999004303.SGD","IE00B2B36J28.USD","LU0708994859.HKD","LU2092937221.SGD","LU0029864427.USD","IE00BKPKM429.USD","BK4566","LU0672654240.SGD","BK4588","LU1803068623.USD","LU0114720955.EUR","TMED","GNMX","STE","IE00BJJMRZ35.SGD","LU0316494557.USD","LU0320765059.SGD","LU1923622614.USD","BK4535","LU1712237335.SGD","LU2089984988.USD","LU0820561818.USD","LU2720916845.USD","IHI","LU2360108059.USD","LU0057025933.USD","LU0157215616.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667062145","title":"Guardant Health Could Benefit From AstraZeneca Trial Failure, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2667062145","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667062145?lang=en_us&edition=fundamental","pubTime":"2026-09-16 03:02","pubTimestamp":1789498945,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) stands to benefit from AstraZeneca's (AZN) failed Serena-4 trial because the result preserves the biomarker-driven monitoring approach supporting potential demand for its Guardant","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AZN","EKG","LU2237443978.SGD","LFSC","LU0128525929.USD","LU2089984988.USD","BK4551","LU2237443622.USD","LU2237443895.HKD","BK4535","LU0058720904.USD","LU0289739699.SGD","LU2236285917.USD","BK4585","LU0029864427.USD","GDOC","GH","LU2237443465.HKD","LU0310800379.SGD","LU2462157665.USD","GNMX","LU1829250122.USD","LU2456880835.USD","BK4007","BK4568","LU2237443382.USD","AZNH","LU2417539215.USD","LU0432979614.USD","FFOX","LU2237443549.SGD","GNOM","LU0109394709.USD","LU0708994859.HKD","BK4588","LU2468319806.SGD","BK4196","HELX","PTH","IE00B3T34201.USD","LU0320765992.SGD","LU0889565916.HKD","LU1267930573.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667629107","title":"Illumina Inc Stock (ILMN) Moved Up by 7.40% on Sep 15: Drivers Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2667629107","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667629107?lang=en_us&edition=fundamental","pubTime":"2026-09-16 01:15","pubTimestamp":1789492530,"startTime":"0","endTime":"0","summary":"• UBS upgraded Illumina to Buy with a price target of $260.\n• Illumina will rejoin the S&P 500 index from the S&P MidCap 400.\n• The company reported strong NovaSeq X demand and consecutive earnings beats.","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262169251-market-movers-ilmn-20260915","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029874061.USD","BK4585","BK4121","BK4588","ILMN","LU0128526141.USD","BK4535","BK4548","GNMX","GNOM","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667671746","title":"ASX biotech expands diagnostics portfolio after FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2667671746","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667671746?lang=en_us&edition=fundamental","pubTime":"2026-09-16 00:00","pubTimestamp":1789488000,"startTime":"0","endTime":"0","summary":"Telix Pharmaceutical’s (ASX.TLX) Pixclara becomes the first positron emission tomography, or PET, imaging agent for glioma brain cancer to receive approval from the US Food and Drug Administration.Why","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["TBXU","SYNB","LABU","IEIH","BBP","BK4588","MEDI","PSCH","IDNA","IYH","PINK","TECB","FRTY","GNMX","NVIB","MRNY","RSPH","BMED","XBIX","MRNX","XLVX","IBB","LFSC","BK4585","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667234796","title":"NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-09-15","url":"https://stock-news.laohu8.com/highlight/detail?id=2667234796","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667234796?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:01","pubTimestamp":1789484480,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-09-15Nasdaq 100.NDXTop PerformersPercent ChangeQUALCOMM IncorporatedQCOM.OQ+3.4%ARM Holdings PLCARM.OQ+3.1%Marvell Techno","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL8N457167:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARMA","IETC","WLDR","LU0082616367.USD","LU0203347892.USD","LU2236285917.USD","LU1923623000.USD","BK4579","BK4527","MSTW","LU0109394709.USD","LU0354030511.USD","LU0979878070.USD","LU1988902786.USD","03034","APED","LMI3.UK","LU0057025933.USD","LU0456842615.SGD","LU0823421333.USD","CHPS","TEXX","03455","LU1861558580.USD","LU2264538146.SGD","IE00BN8TJ469.HKD","MRVL","EYES","LU1066053197.SGD","LU0823411888.USD","LU2361044865.SGD","LU1242518857.USD","3SMI.UK","LU2931357623.SGD","LU0823434740.USD","CNAV","LU0672654240.SGD","LU1803068979.SGD","LU1880398554.USD",".HXC","LU2361044949.HKD","LU0175139822.USD","LU0187121727.USD","EGGY","LU0061475181.USD","LU2265009873.SGD","LU0444971666.USD","LU1861220033.SGD","LU0320765059.SGD","LU2098885051.SGD","ARM","FTXL","BK4187","BK4516","FDTX","BK4600","LU2473716301.USD","IE00BMPRXQ63.HKD","ARMW","BK4141","IE00BLSP4239.USD","TQQY","ALNY","LU2462591350.SGD","LU1244550577.SGD","LU0154236417.USD","DISK","LU0889565833.HKD","MVLL","ARMU","AIQ","LU0048573561.USD","MST","LU2097829019.USD","LU0050427557.USD","IE00BMPRXR70.SGD","LU0289739343.SGD","LU1303367103.USD","IE00B0JY6N72.USD","LU1046421795.USD","LU0511384066.AUD","BK4588","07568","MSTK","AXON","LU1069344957.HKD","07399","MSTX","LU1496350502.SGD","LU1670628061.USD","LU0823434583.USD","STXL","LU0532187761.SGD","BK4585","LU0289961442.SGD","BK4595","STX","LU0251142724.SGD","MSTY.UK","AIFD","07261","AMYY","MRVU","GUNZ","IE00B8HQ1Z84.USD","LU1989772923.USD","XNTK","LU1983260115.SGD","LU0320765992.SGD","09834","IE00B1BXHZ80.USD","LU0079474960.USD","LU1852331112.SGD","LU2211815571.USD","BK4566","ILDR","LU2242649171.HKD","LU1823568750.SGD","LU1974910355.USD","LU2247934214.USD","AXUP","LU1951198990.SGD","LU1989764664.SGD","BK4575","LU0053687314.USD","LU2860962120.EUR","LU1861220207.SGD","SG9999001424.SGD","BK4023","IE0004086264.USD","LU0266013472.USD","LEGR","LU1267930730.SGD","IE00BZ1G4Q59.USD","AMDS","MSDD","LU0109392836.USD","LU1066051498.USD","SPRX","NDX","LU1642822529.SGD","IE00B5949003.HKD","LU0552385451.USD","LU2272731782.SGD","LU1992135472.HKD","SG9999015945.SGD","09399","LU1169590202.USD","DTCR","SMI3.UK",".IXIC","BK4573","IE0004091025.USD","ARMG","LU2322448957.HKD","STXU","WUGI","LU0354030438.USD","LU0198837287.USD","LU0742534661.SGD","LU2458330243.SGD","QQQX","IE00BBT3K403.USD","LU0431992006.USD","PBE","IE00BGHQDM52.EUR","LU0957808578.USD","NAPR","WNTR","LU0868494708.USD","FXL","LU1992135399.USD","LU2125909916.SGD","LU0792757196.USD","SG9999015978.USD","09086","LU0274383776.USD","LU2290526834.HKD","BK4543","LU0823421416.USD","AMDU","LU0251131958.USD","OWNB","AMDL","LU1244550221.USD","SOXX","BK4604","LU1035775433.USD","HK0000914660.USD","BK4213","LU0143863784.USD","SGXZ99366536.SGD","IE00BGHQF524.EUR","BK4609","AMDD","FAI","LU0786609619.USD","09799","LU2272731600.USD","02834","HK0000914686.HKD","LU1868838027.USD","IE00BGV7N243.SGD","BAI","BK4534","SMST","ONLN","LU2063271972.USD","LU0889565916.HKD","IE00B8L5B284.USD","PSI","MSTP","SQCOMmain","AMD","IE00BVYPNP33.GBP","BK4548","LU0107464264.USD","LU0868486357.SGD","ARTY","MELI","QMAR","LU0289960550.SGD","QQQA","KMLI","07522","NJUL","LU0203345920.USD","BK4532","GPIQ","IE00B2Q91V27.USD","LU2461242641.AUD","LU1720051017.SGD","MSTY","DAMD","AMDG","LU1868837565.USD","SMH","PSQ","SG9999015952.SGD","IE0001KFT4U8.USD","GTEK","LU0889566641.SGD","USXF","LU2458330169.SGD","LU0081259029.USD","LU0056508442.USD","MRVX","LU2360107671.USD","OILT","LU1861215975.USD","IE00BQXX3D17.EUR","LU1232071149.USD","IE00BSNM7G36.USD","IE00B19Z9P08.USD","LU1880398471.USD","FANG","IE00B0169N27.USD","LU1084165304.USD","MSOO","FCUS","LU0251132253.USD","NJAN","BK4512","QQQ","AIS","TTEQ","MSTU","LU2357305700.SGD","QCMU","MSTZ","QQQM","LU0127658192.USD","LU1066051225.USD","LU2896262040.SGD","MTYY","LU2244417387.USD","LU1548497426.USD","IE00BKVL7J92.USD","LU1261432733.SGD","IE00B894F039.SGD","BK4220","SGXZ81514606.USD","IE00B1B80R65.USD","LU0642271901.SGD","LU0719512351.SGD","LU0174119429.USD","SG9999015986.USD","LU0942090050.USD","QQQG","BK4561","3LMI.UK","LU2106854487.HKD","CRPT","QLD","SG9999002224.SGD","SOXY","BK4122","LU2125909759.SGD","LU0708995401.HKD","LU1267930813.SGD","LU2023250504.SGD","BK4596","07266","AMDC","STXX","LU1804176565.USD","03086","BK4598","RULE","LU2279701549.SGD","BK4614","LU2054465674.USD","LU0114720955.EUR","BK4529","LU1989772840.SGD","IE00BQXX3F31.USD","LU2250418816.HKD","LU1670627923.USD","DRMY","LU2108987350.USD","LU1064131342.USD","LU1917777945.USD","LU1244550494.USD","IE0009356076.USD","IE00B19Z9Z06.USD","QCMD","QDEC","LU2543165471.USD","WISE","LU1242518931.SGD","LU1235294995.USD","LU2272731865.HKD","LU1861559042.SGD","AMDY","LU0868494617.USD","GNMX","CHAT","SG9999002232.USD","TRFK","LU1861217088.USD","LU2355687059.USD","LU2322448791.USD","IMST","LU1951200564.SGD","LU2456880835.USD","XAR","TQQQ","BK4612","LU0106959298.USD","AIPI","LU0882574055.USD","LU1989764748.USD","SQQQ","LU0143863198.USD","LU1119994496.HKD","QCML","MSTC","BITQ","IE00BMPRXN33.USD","LU0048584097.USD","SGXZ51526630.SGD","TEK","SG9999000418.SGD","LU1066051811.HKD","BK4170","LU0210536198.USD","IE00BQXX3C00.GBP","LU1316542783.SGD","BK4605","SMHX","IE00BLSP4452.SGD","BK4515","07799","LU2361045086.USD","QID","SAMD0main","MSII","AMUU","LU0210535034.USD","LU0069063385.USD","LU2417539215.USD","LU2360107168.USD","GB00BDT5M118.USD","LU1815336760.USD","LU2089985449.USD","BK4554","BK4581","LU0472753341.HKD","MSTR","LU2360106780.USD","BK4139","LU0133085943.USD","LU0444973449.USD","LU0348723411.USD","AMDW","LU1923622291.USD","TDV","MSST","IE0004445239.USD","LU1720051108.HKD","LU1169589451.USD","LU0476273544.USD","LU0109391861.USD","QCOM","IE00B3CCJ963.GBP","LU0390134368.USD","GAMR","IE00BVYPNQ40.USD","LU1868837722.USD","NOCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667628546","title":"Thermo Fisher Exec Says Academic and Government Research Market Should Return to Growth in 2027 - Morgan Stanley Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2667628546","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667628546?lang=en_us&edition=fundamental","pubTime":"2026-09-15 21:59","pubTimestamp":1789480777,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570G6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4581","LU1061106388.HKD","LU1988902786.USD","LU1989771016.USD","LU2092937221.SGD","LU1803068623.USD","IE00BKPKM429.USD","LU0320765489.SGD","IE00BFTCPJ56.SGD","LU1623119135.USD","LU0251131958.USD","LU0266013472.USD","GNMX","TMO","LU1023059063.AUD","LU0557290698.USD","LU2543165471.USD","LU0316494557.USD","LU2211814178.USD","LU0251142724.SGD","LU0708994859.HKD","LU2125909247.SGD","LU2720916845.USD","LU1854104046.USD","LU1633808545.USD","BK4548","HRTS","IE00B4R5TH58.HKD","LU0640476718.USD","LU1720051017.SGD","LU1291159041.SGD","LU2211815571.USD","LU0345770993.USD","LU2764262908.HKD","BK4535","LU0310800379.SGD","LU0234572021.USD","IE00B19Z9505.USD","LU1791710582.SGD","TMED","LU0742534661.SGD","LU1280957306.USD","BK4533","FMED","LU0122379950.USD","IE0034235188.USD","IE00BJJMRZ35.SGD","LU1670628061.USD","LU1791710400.SGD","LU0528227936.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667361628","title":"Thermo Fisher Exec Says Orders are Outpacing Revenue, Boding Well for Future Growth- Morgan Stanley Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2667361628","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667361628?lang=en_us&edition=fundamental","pubTime":"2026-09-15 21:59","pubTimestamp":1789480777,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570G6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GNMX","LU0528227936.USD","LU0823416689.USD","LU2063271972.USD","BK4588","LU2433249047.HKD","LU2125909247.SGD","LU1267930573.SGD","LU2264538146.SGD","FMED","LU0128525929.USD","LU0048573561.USD","LU0234572021.USD","LU0345770308.USD","LU0114720955.EUR","LU0061474960.USD","LU1057294990.SGD","LU2125910179.SGD","LU1923621640.USD","LU2357305700.SGD","LU2468319806.SGD","LU0342679015.USD","LU1854104046.USD","IE00BQXX3F31.USD","LU0345770993.USD","IE00BJT1NW94.SGD","LU2298321311.HKD","LU2092937221.SGD","BK4581","HRTS","LU0557290698.USD","TMO","IE00B19Z9505.USD","LU1803068623.USD","LU1670627923.USD","TMED","LU1670628061.USD","LU2764262908.HKD","LU2211814178.USD","LU2764263203.CNY","IE0002141913.USD","LU1548497426.USD","LU1989771016.USD","LU2089984988.USD","LU1791710582.SGD","LU1720051108.HKD","LU2764263039.SGD","LU2125910336.SGD","LU2041044095.USD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667644412","title":"Mayo Clinic and Thermo Fisher Scientific Launch Precure, Llc to Identify Signs of Disease Before Symptoms Appear","url":"https://stock-news.laohu8.com/highlight/detail?id=2667644412","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667644412?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:00","pubTimestamp":1789473607,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nTUA9M2KLH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TMO","GB00BDT5M118.USD","BK4535","IE00B4R5TH58.HKD","LU2211814178.USD","LU1064131342.USD","LU0208291251.USD","LU1548497426.USD","LU0234572021.USD","LU1720051108.HKD","LU1983299246.USD","LU1623119135.USD","BK4548","LU1815333072.USD","LU2764263203.CNY","LU2089984988.USD","LU2041044095.USD","IE0034235188.USD","LU1720051017.SGD","LU2063271972.USD","LU2125910336.SGD","IE0009355771.USD","TMED","LU1988902786.USD","LU0048573561.USD","LU1670627923.USD","LU1923622291.USD","LU0310800379.SGD","IE00BJJMRZ35.SGD","LU2298321311.HKD","IE00BQXX3D17.EUR","GNMX","LU2720916845.USD","LU0345770308.USD","IE00BFTCPJ56.SGD","LU0029864427.USD","LU0432979614.USD","FMED","LU0266013472.USD","HRTS","LU0316494557.USD","BK4585","LU1803068623.USD","LU1023059063.AUD","LU0345770993.USD","LU1153585028.USD","LU2125909593.SGD","LU2264538146.SGD","LU1633808545.USD","LU0251142724.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667644589","title":"Vertex Pharmaceuticals partners with Lindsey Vonn for JOURNAVX awareness","url":"https://stock-news.laohu8.com/highlight/detail?id=2667644589","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667644589?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:36","pubTimestamp":1789472175,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals (VRTX) has partnered with world champion skier Lindsey Vonn to raise awareness of JOURNAVX, a prescription non-opioid medici...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-partners-with-lindsey-vonn-for-journavx-awareness-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-partners-with-lindsey-vonn-for-journavx-awareness-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z9Z06.USD","LU1674673691.USD","LU2362541273.HKD","LU2362541513.USD","IE00BJJMRZ35.SGD","LU2362540622.SGD","LU0823416689.USD","IBB","LU1674673428.USD","BK4532","BK4533","IE00B19Z9P08.USD","IE00BJT1NW94.SGD","SG9999001176.USD","SG9999013999.USD","VRTX","SGXZ57979304.SGD","VERX","BK4023","BK4588","BK4585","LU0234570918.USD","IE00B19Z3B42.SGD","LU1559883803.SGD","LU0256863811.USD","LU0757428866.USD","LU1069344957.HKD","IDNA","TBXU","LU0061475181.USD","BIB","LU2456880835.USD","IE00B2B36J28.USD","LU0109394709.USD","BK4567","IE00BFTCPJ56.SGD","BBH","LU2468319806.SGD","PBE","IE0009355771.USD","IE0002141913.USD","LU1035775433.USD","LU2237438978.USD","SG9999001176.SGD","LU1430594728.SGD","GNMX","LU0566484027.USD","IBBQ","LU1093756325.SGD","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667641173","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC), Natera (NTRA) and Vertex Pharmaceuticals (VRTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667641173","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667641173?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:20","pubTimestamp":1789471221,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Centene (CNC), Natera (NTRA) and Vertex Pharmaceut...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-centene-cnc-natera-ntra-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-centene-cnc-natera-ntra-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","LU0053671581.USD","HCSG","LU0234570918.USD","LU0823416689.USD","CNC","LU1988902786.USD","IBB","LU1035775433.USD","BIB","GNOM","IBBQ","BK4567","VRTX","HELX","LU1291159041.SGD","LU0012050646.USD","LU0648000940.SGD","XBI","LU0859254822.USD","BK4023","IE00B19Z3581.USD","IE00B19Z9Z06.USD","XLV","IDNA","NTRA","BK4154","LU2462157665.USD","LU1430594728.SGD","IE0002270589.USD","TBXU","LU0130518102.USD","LU2456880835.USD","BK4137","LU2065169927.USD","LU2065171311.SGD","LU0128526141.USD","LU2236285917.USD","CNCG","BK4581","BK4139","LU1585245621.USD","LU1674673691.USD","BK4585","LABU","BBH","PBE","LU0289739699.SGD","GNMX","VERX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667643557","title":"Barclays downgrades Scholar Rock on valuation after FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2667643557","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667643557?lang=en_us&edition=fundamental","pubTime":"2026-09-15 17:10","pubTimestamp":1789463419,"startTime":"0","endTime":"0","summary":"Barclays analyst Etzer Darout downgraded Scholar Rock (SRRK) to Equal Weight from Overweight with a price target of $58, up from $55. The approval ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/barclays-downgrades-scholar-rock-on-valuation-after-fda-approval-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/barclays-downgrades-scholar-rock-on-valuation-after-fda-approval-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PINK","LABU","TACU","CDIG","RSPH","IEIH","MEDI","GDOC","TSPA","LFSC","SYNB","BMED","PSCH","MRNY","TBXU","TECB","NVIB","GNMX","FRTY","IYH","IBB","IDNA","BBP","XLVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667569983","title":"Guardant Health CIO Kumud Kalia Disposes of 4,000 Common Shares Worth $632,193.20","url":"https://stock-news.laohu8.com/highlight/detail?id=2667569983","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667569983?lang=en_us&edition=fundamental","pubTime":"2026-09-15 06:12","pubTimestamp":1789423938,"startTime":"0","endTime":"0","summary":"Guardant Health CIO Kumud Kalia disposes of 4,000 common shares worth $632,193.20Guardant Health Chief Information Officer Kumud Kalia sold 4,000 common shares on Sept. 11, 2026.The sale price was USD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL3DVtS3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health CIO Kumud Kalia Disposes of 4,000 Common Shares Worth $632,193.20","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","EKG","GNOM","HELX","LU0889565916.HKD","GNMX","GDOC","GH","FFOX","LFSC","LU0320765992.SGD","BK4535","BK4196","LU0109394709.USD","BK4585","BK4551","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667869541","title":"Niki BioSolutions Highlights Strategic Synergies in Alzheimer’s Diagnostics","url":"https://stock-news.laohu8.com/highlight/detail?id=2667869541","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667869541?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:37","pubTimestamp":1789418272,"startTime":"0","endTime":"0","summary":"Niki BioSolutions Inc ( ($NIKI) ) just unveiled an announcement. Niki BioSolutions Inc operates in the biotechnology and molecular diagnostics sect...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/niki-biosolutions-highlights-strategic-synergies-in-alzheimers-diagnostics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/niki-biosolutions-highlights-strategic-synergies-in-alzheimers-diagnostics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED","FWD","IEIH","BBP","GNMX","IBB","RSPH","LNGR","HELX","BK4585","SYNB","JDOC","DARP","BK4588","XT","AGNG","FHLC","HTEC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667087693","title":"Guardant Health, - Evicore by Evernorth to Cover Shield Blood Test for Crc Screening Effective Jan 1, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2667087693","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667087693?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:07","pubTimestamp":1789416443,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nFWN4560HZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","LU0889565916.HKD","LFSC","FFOX","GH","PTH","EKG","BK4588","GNOM","BK4551","HELX","BK4196","LU0320765992.SGD","GNMX","LU0109394709.USD","BK4535","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661630","title":"Biofrontera announces FDA approval of Ameluz supplemental new drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661630","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661630?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:35","pubTimestamp":1789392922,"startTime":"0","endTime":"0","summary":"Biofrontera (BFRI) announced that the FDA has approved the company’s supplemental new drug application, or sNDA, for Ameluz topical gel, 10%, in co...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDI","IDNA","BMED","LFSC","BFRI","FRTY","MRNY","TBXU","GDOC","TECB","SYNB","LABU","BBP","GNMX","PINK","IYH","PSCH","NVIB","BK4007","IBB","BK4585","MRNX","RSPH","XLVX","BK4588","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667066661","title":"Scholar Rock Wins FDA Approval for SMA Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2667066661","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667066661?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:32","pubTimestamp":1789389127,"startTime":"0","endTime":"0","summary":"The latest update is out from Scholar Rock Holding ( ($SRRK) ). On September 11, 2026, Scholar Rock announced U.S. FDA approval of ISEMBYLD (apiteg...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNX","PSCH","BBP","BMED","RSPH","BK4585","IBB","SYNB","BK4588","IYH","LABU","TECB","NVIB","MRNY","FRTY","IDNA","LFSC","PINK","GDOC","MEDI","XLVX","TBXU","GNMX","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667134663","title":"Scholar Rock price target raised to $84 from $76 at BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2667134663","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667134663?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:36","pubTimestamp":1789385772,"startTime":"0","endTime":"0","summary":"BMO Capital raised the firm’s price target on Scholar Rock (SRRK) to $84 from $76 and keeps an Outperform rating on the shares. The FDA approval of...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","THNR","IBB","IYH","FRTY","MEDI","SRRK","XLVX","IBRN","IDNA","BK4588","MRNX","LFSC","NVIB","TBXU","PSCH","IEIH","RSPH","BBP","BK4139","TECB","BK4585","LABU","MRNY","BMED","GNMX","SYNB","PINK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667376655","title":"Cellectis pivots to in vivo gene editing and exits key CAR-T programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2667376655","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667376655?lang=en_us&edition=fundamental","pubTime":"2026-09-14 15:15","pubTimestamp":1789370144,"startTime":"0","endTime":"0","summary":"Cellectis SA ( ($FR:ALCLS) ) has provided an announcement. Cellectis has approved a strategic shift to focus on in vivo gene editing, advancing two...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cellectis-pivots-to-in-vivo-gene-editing-and-exits-key-car-t-programs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cellectis-pivots-to-in-vivo-gene-editing-and-exits-key-car-t-programs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","WDNA","IDNA","SYNB","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667653981","title":"Cellectis Announces Strategic Transformation To In Vivo Gene Editing Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2667653981","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667653981?lang=en_us&edition=fundamental","pubTime":"2026-09-14 14:40","pubTimestamp":1789368000,"startTime":"0","endTime":"0","summary":"Cellectis to advance two lead in vivo programs .HEAL-101 and .HEAL-201 in severe dyslipidemias with preliminary Phase 1 data planned in H2 2027 and H1 2028, respectivelyTransformation supported by con","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/14/3360712/0/en/cellectis-announces-strategic-transformation-to-in-vivo-gene-editing-company.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NC","HELX","IDNA","BK4139","GNMX","BK4156","HEAL","SYNB","CLLS","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667635488","title":"Vertex Minerals Revises Timeline for Proposed Securities Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2667635488","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667635488?lang=en_us&edition=fundamental","pubTime":"2026-09-14 07:40","pubTimestamp":1789342824,"startTime":"0","endTime":"0","summary":"Vertex Minerals Ltd. ( ($AU:VTX) ) has provided an update. Vertex Minerals Ltd. has updated its proposed securities placement timetable, revising t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-revises-timeline-for-proposed-securities-issue?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-revises-timeline-for-proposed-securities-issue?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1674673428.USD","IE00BJT1NW94.SGD","SGXZ57979304.SGD","BK4533","IE00B19Z9P08.USD","LU1674673691.USD","IE00B2B36J28.USD","BK4109","BK4588","TBXU","LU0061475181.USD","LU2362541273.HKD","IDNA","IE00B894F039.SGD","LU0256863811.USD","IE0009355771.USD","LU1585245621.USD","SG9999001176.SGD","LU1430594728.SGD","LU1815336091.USD","LU0417517546.SGD","BBH","IE00BJJMRZ35.SGD","VRTX","PBE","LU0079474960.USD","LU1093756325.SGD","GNMX","LU0757428866.USD","LU0109394709.USD","LU0234570918.USD","LU0320765992.SGD","LU2089984988.USD","IE00BZ9MQY76.HKD","VERX","MTX","SG9999001176.USD","IBBQ","BK4585","IE00B4R5TH58.HKD","LU0058720904.USD","LU0432979614.USD","LU1559883803.SGD","LU0566484027.USD","LU2468319806.SGD","LU0889565916.HKD","BK4532","BIB","IBB","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}